fig2

Inflammation-targeted nanomedicines for atherosclerotic cardiovascular disease: from atherosclerosis regression to post-myocardial infarction management

Figure 2. Illustration of inflammatory mechanisms and cellular targets in ASCVD: (A) the cascade from endothelial dysfunction to inflammatory amplification; (B) targeting adhesion molecules on endothelial cells to block leukocyte infiltration; and (C) plaque targeting and suppression of inflammatory signaling. Created with BioRender. Yang, G. (2026). https://BioRender.com/kp4oush. ASCVD: Atherosclerotic cardiovascular disease; LDL: low-density lipoprotein; NLRP3: NLR family pyrin domain containing 3; IL-1β: interleukin-1β; ECs: endothelial cells; CD44: cluster of differentiation 44; TLR2: Toll-like receptor 2; TLR4: Toll-like receptor 4.